XML 19 R8.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2023   1,000,000.0      
Beginning balance at Dec. 31, 2023 $ 2.7 $ 0.0 $ 1,024.5 $ (1,014.3) $ (7.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 33.5     33.5  
Other comprehensive income (loss) (3.6)       (3.6)
Stock-based compensation 0.3   0.3    
Dividends to Sponsor Stockholder (382.7)     (382.7)  
Ending balance (in shares) at Mar. 31, 2024   1,000,000.0      
Ending balance at Mar. 31, 2024 $ (349.8) $ 0.0 1,024.8 (1,363.5) (11.1)
Beginning balance (in shares) at Dec. 31, 2024 379,792,996 379,800,000      
Beginning balance at Dec. 31, 2024 $ 3,444.2 $ 3.8 4,971.3 (1,513.7) (17.2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 28.7     28.7  
Other comprehensive income (loss) 4.5       4.5
Common shares repurchased and cancelled (in shares)   (4,200,000)      
Common shares repurchased and cancelled (119.2)   (5.1) (114.1)  
Issuance of common stock (in shares)   600,000      
Issuance of common stock 1.2   1.2    
Stock-based compensation 12.0   12.0    
Dividends on common stock ($0.10 per share) $ (38.3)     (38.3)  
Ending balance (in shares) at Mar. 31, 2025 376,197,105 376,200,000      
Ending balance at Mar. 31, 2025 $ 3,333.1 $ 3.8 $ 4,979.4 $ (1,637.4) $ (12.7)